Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BSE (bovine spongiform encephalopathy) panic reactions in Europe shake device manufacturers

This article was originally published in Clinica

Executive Summary

There is an increasing sense of urgency among the European authorities for action to safeguard patients against the potential risk of transferring bovine spongiform encephalopathy (BSE) through the use of medical devices. Some member states have lost patience waiting for the publication of the Commission's decision on European requirements for medical devices containing animal-derived products, which has been pending for some time (see Clinica No 948, p 4), and taken unilateral action.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT070374

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel